Abstract
BACKGROUND: Transcatheter mitral valve repair (TMVr), using MitraClip(®), is a safe and effective procedure for severe mitral valve regurgitation (MR). However, the therapeutic results of MitraClip(®) in Qatar remain to be elucidated. A total of 25 patients (mean age 60 ± 14.5 years, 64% males) with symptomatic severe MR and prohibitive surgical risks were enrolled in this study. The procedural success rate was 92% to achieve mild residual MR. There was no periprocedural death. All patients experienced significant improvement in heart failure symptoms and MR grade postprocedure with sustained improvement over 1-year follow-up. CONCLUSION: The TMVr procedure using the MitraClip(®) device was safe and resulted in meaningful and sustained functional status and echocardiographic parameter improvement.